Stoke Therapeutics (STOK) Other Non Operating Income: 2022-2025
Historic Other Non Operating Income for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $3,000.
- Stoke Therapeutics' Other Non Operating Income fell 89.29% to $3,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $260,000, marking a year-over-year increase of 163.88%. This contributed to the annual value of -$247,000 for FY2024, which is 248.80% down from last year.
- According to the latest figures from Q3 2025, Stoke Therapeutics' Other Non Operating Income is $3,000, which was down 89.29% from $28,000 recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Other Non Operating Income registered a high of $201,000 during Q4 2024, and its lowest value of -$428,000 during Q1 2024.
- In the last 3 years, Stoke Therapeutics' Other Non Operating Income had a median value of $28,000 in 2025 and averaged -$2,091.
- Within the past 5 years, the most significant YoY rise in Stoke Therapeutics' Other Non Operating Income was 390.24% (2024), while the steepest drop was 1,119.05% (2024).
- Quarterly analysis of 4 years shows Stoke Therapeutics' Other Non Operating Income stood at $42,000 in 2022, then decreased by 2.38% to $41,000 in 2023, then surged by 390.24% to $201,000 in 2024, then plummeted by 89.29% to $3,000 in 2025.
- Its Other Non Operating Income was $3,000 in Q3 2025, compared to $28,000 in Q2 2025 and $28,000 in Q1 2025.